Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Nuokang Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of hematological and cardiovascular products. The company is best known for its flagship product, Baquting (Hemocoagulase Atrox), a snake venom-derived procoagulant used to treat various types of bleeding. Nuokang operates as a key subsidiary within the broader Nuokang Biopharmaceutical group, maintaining large-scale GMP-certified manufacturing facilities in Shandong province. Its portfolio includes a range of prescription drugs focused on blood management, cardiovascular health, and pain management, serving the domestic Chinese hospital market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Nuohokang Pharmaceutical.